833 abstracts found.



Results filter



Polygenic risk prediction: The clinical significance

Year:

Session type:

Paul Pharoah
University of Cambridge, UK



Unexplained familial breast cancer risk – how can we find the missing genes?

Year:

Session type:

Julian Peto
London School of Hygiene and Tropical Medicine, UK



Interrogating regulatory networks to elucidate drivers of tumourigenesis, progression, and drug sensitivity

Year:

Session type:

Andrea Califano
Columbia University, New York, USA



Translating pre-clinical hypotheses into the clinic – a tale of two kinases

Year:

Session type:

Nigel Brooks
AstraZeneca, Macclesfield, UK



Improvements in palliative and supportive care: recent advances

Year:

Session type:

Irene Higginson
Cicely Saunders Institute, King’s College London, UK



Intravital microscopy of tumour cells and their microenvironment through imaging windows

Year:

Session type:

Jacco van Rheenen
Hubrecht Institute, Utrecht, The Netherlands



Developing novel anti-cancer therapies: Promises and challenges

Year:

Session type:

Jeff Evans
The Beatson Institute for Cancer Research, University of Glasgow & NHS Greater Glasgow and Clyde, Glasgow, UK



Advances, challenges and opportunities in symptom management in older patients with cancer

Year:

Session type:

Deborah Dudgeon
Queen's University, Ontario, Canada



Where next with genome-wide association studies?

Year:

Session type:

Bruce Ponder
Cancer Research UK Cambridge Research Institute, UK



Delivering on the promise of personalised medicine.

Year:

Session type:

Gordon Mills
The University of Texas MD Anderson Cancer Center, USA

Page 1 of 841...25...Last »